Enteric infections due to Escherichia coli

Clinical Microbiology and Infection

Volumn 4, Issue 1, 1998, Pages 38-43

  Garcia, Marie Isabelle ^a   Le Bouguénec, Chantai ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VIRULENCE FACTOR;

BACTERIAL VIRULENCE; BIOCHEMISTRY; ESCHERICHIA COLI; GENETIC ANALYSIS; INTESTINE INFECTION; MICROBIOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SERODIAGNOSIS;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 0031975916     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.1998.tb00332.x     Document Type: Article

References (23)

1. Riley LW, Remis RS, Helgerson SD, et al. Haemorrhagic colitis associated with a rare Escherichia coli. New Engl J Med 1983; 308: 681-5.
2. Cowden JM. Scottish outbreak of Escherichia coli O157 November-December 1996. Euro surveillance 1997; 2: 1-2.
3. Garcia MI, Le Bouguénec C. Role of adhesion in pathogenicity of human uropathogenic and diarrheagenic Escherichia coli. Bull Inst Pasteur 1996; 94: 201-36.
4. Nataro JP, Hicks S, Phillips AD, Vial PA, Sears CL. T84 cells in culture as a model for enteroaggregative Escherichia coli pathogenesis. Infect Immun 1996; 64: 4761-8.
5. Germani Y, Begaud E, Duval P, Le Bouguénec C. Prevalence of enteropathogenic, enteroaggregative, and difiuselyadherent Escherichia coli among isolates from children with diarrhea in New Caledonia J Infect Dis 1996; 174: 1124-6.
6. Levine MM, Ferreccio C, Prado V, et al. Epidemiologic studies of Escherichia coli diarrheal infections in a low socioeconomic level peri-urban community in Santiago, Chile. Am J Epidemiol 1993; 138: 849-69.
7. van de Kar NC, Roelofs HG, Muytjens HL, et al. Verocytotoxin-producing Escherichia coli infection in haemolytic uraemic syndrome in part of western Europe. Eur J Pediatr 1996; 155: 592-5
8. Bielaszewska M, Janda J, Blahova K, et al. Verocytotoxin-producing Escherichia coli in children with haemolytic uraemic syndrome in the Czech Republic. Clin Nephrol 1996; 46: 42-4.
9. Ludwig K, Bitzan M, Zimmermann S, et al Immune response to non-O157 Vero toxin-producing Escherichia coli in patients with haemolytic uraemic syndrome. J Infect Dis 1996; 174: 1028-39.
10. Griffin PM. Escherichia coli O157:H7 and other enterohaemorrhagic Escherichia coli. In Blaser MJ, Smith PD. Ravdin JI, Greenberg HB, Guerrant RL, eds. Infections of the gastrointestinal tract. New York: Raven Press, 1995: 739-61.
11. Belongia EA, Osterholm MT, Soler JT, Ammend DA, Braun JE, MacDonald KL. Transmission of Escherichia coli O157:H7 infection in Minnesota child day-care facilities. JAMA 1993; 269: 883-8.
12. Tarr PI. Escherichia coli O157:H7: clinical diagnostic, and epidemiological aspects of human infection. Clin Infect Dis 1995; 20: 1-10.
13. Tschape H, Prager R, Streckel W, Fruth A, Tietze E, Bohme G. Verotoxinogenic Citrobacter freundii associated with severe gastroenteritis and cases of haemolytic uraemic syndrome in a nursery school: green butter as the infectious source. Epidemiol Infect 1995; 114: 441-50.
14. Paton AW, Paton JC. Enterobacter cloacae producing a shigalike toxin II-related cytotoxin associated with a case of haemolytic-uraemic syndrome. J Clin Microbiol 1996; 34: 463-5.
15. Butler T, Islam MR, Azad MAK, Jones PK. Risk factors for development of haemolytic uraemic syndrome during shigellosis. Pediatrics 1987; 110: 894-7.
16. Tesh VL, O'Brien AD. The pathogenic mechanisms of shiga toxin and the shiga-like toxins. Mol Microbiol 1991; 5: 1817-22.
17. Melton-Celsa AR, Darnell SC, O'Brien AD. Activation of shiga-like toxins by mouse and human intestinal mucus correlates with virulence of enterohaemorrhagic Escherichia coli O91:H21 isolates in orally-infected, streptomycin-treated mice. Infect Immun 1996; 64: 1569-76.
18. Pollard DR, Johnson WM, Lior H, Tyler SD, Rozee KR Rapid and specific detection of verocoxin genes in Escherichia coli by the polymerase chain reaction. J Clin Microbiol 1990; 28: 540-5.
19. Germani Y, Begaud E, Le Bouguénec C. Detection of the Escherichia coli attaching and effacing gene (eaeA) in enteropathogenic strains by polymerase chain reaction. Res Microbiol 1997; 148: 177-81.
20. Ostroff SM, Kobayashi JM, Lewis JH. Infections with Escherichia coli O157:H7 in Washington State. The first year of statewide disease surveillance. JAMA 1989; 262: 355-9.
21. Pavia AT, Nichols CR, Green DP, et al. Haemolytic-uraemic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally-retarded persons: clinical and epidemiologic observations. J Pediatr 1990; 116: 544-51.
22. Proulx F, Turgeon JP, Delage G, Lafleur L, Chicoine L. Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritis. J Pediatr 1992; 121: 299-303.
23. Cimolai N, Carter JE, Morrison BJ, Anderson JD. Risk factors for the progression of Escherichia coli O157:H7 enteritis to haemolytic-uraemic syndrome J Pediatr 1990; 116: 589-92.